Skip to main content
EJNMMI Research

Table 2 Mean BUN at baseline, week 16 and corresponding differences with confidence intervals

From: Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats

BUN (mg/dl)

Baseline

Week 16

Difference (%)

Placebo

16.9 ± 2.1

19.4 ± 1.8

19 ± 27

Everolimus

15.7 ± 2.0

18.3 ± 1.2

15 ± 11

Placebo + [177Lu]Lu-DOTA-TATE

17.9 ± 1.7

19.1 ± 2.2

7 ± 10

Everolimus + [177Lu]Lu-DOTA-TATE

16.9 ± 1.3

19.9 ± 1.1

19 ± 12

Back to article page